Form 4: Legend Biotech CFO Sells Shares
Insider Transaction (Form 4)
Carlos E Santos, Chief Financial Officer of Legend Biotech Corp, sold 5,430 shares of common stock on September 21, 2026 for $9.14 per share.
Summary
- Grant/award: acquired 19,676 Ordinary Shares on September 21, 2026; holds 19,676 after (Direct).
- Open-market sale: disposed of 5,430 Ordinary Shares at $9.14 ($49,630) on September 21, 2026; holds 14,246 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $49,630 of stock on the open market.
Insider Transactions
Carlos E Santos — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-21 | Grant/award | Ordinary Shares | 19,676 | — | — | 19,676 |
| 2026-09-21 | Open-market sale | Ordinary Shares | 5,430 | $9 | $49.6K | 14,246 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-21 | Grant/award (19,676 shares) |
| 2026-09-21 | Open-market sale (5,430 shares) |
Keywords
insider transaction, Form 4, LEGN, Legend Biotech Corp, bearish, Carlos E Santos
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.